These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9259222)

  • 21. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse.
    Moss HB; Yao JK; Panzak GL
    Biol Psychiatry; 1990 Aug; 28(4):325-38. PubMed ID: 2397249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.
    Stoff DM; Pasatiempo AP; Yeung J; Cooper TB; Bridger WH; Rabinovich H
    Psychiatry Res; 1992 Sep; 43(3):263-76. PubMed ID: 1438624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness.
    Coccaro EF; Kavoussi RJ; Trestman RL; Gabriel SM; Cooper TB; Siever LJ
    Psychiatry Res; 1997 Nov; 73(1-2):1-14. PubMed ID: 9463834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood serotonergic function and early adult outcomes in youth with ADHD: A 15-year follow-up study.
    Ivanov I; Flory J; Newcorn JH; Halperin JM
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1429-1438. PubMed ID: 30454909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J; Toll C; Schonlau P; Rohrmann S; Netter P
    Neuropsychobiology; 2000; 41(1):38-47. PubMed ID: 10629434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine correlates of temperamental traits in humans.
    Gerra G; Zaimovic A; Timpano M; Zambelli U; Delsignore R; Brambilla F
    Psychoneuroendocrinology; 2000 Jul; 25(5):479-96. PubMed ID: 10818282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH; O'Keane V; Dinan TG
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment?
    Dolan M; Deakin WJ; Roberts N; Anderson I
    Psychol Med; 2002 Jan; 32(1):105-17. PubMed ID: 11885567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Brodaty H; Boyce P; Hickie I
    Psychiatry Res; 1991 May; 37(2):179-93. PubMed ID: 1652141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review.
    Newman ME; Shapira B; Lerer B
    Int J Neuropsychopharmacol; 1998 Jul; 1(1):49-69. PubMed ID: 11281946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.